Covid-19 breath test startup Breathonix raising US$5m capital
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.